Efficient phosphonium-mediated synthesis of 2-amino-1,3,4-oxadiazoles

Organic Letters

Volumn 10, Issue 9, 2008, Pages 1755-1758

  Levins, Christopher G ^a   Wan, Zhao Kui ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOTRIAZOL 1 YLOXY TRIS(DIMETHYLAMINO)PHOSPHONIUM; BENZOTRIAZOL-1-YLOXY-TRIS(DIMETHYLAMINO)PHOSPHONIUM; ORGANOPHOSPHORUS COMPOUND; OXADIAZOLE DERIVATIVE;

AMINATION; ARTICLE; CHEMISTRY; SYNTHESIS;

AMINATION; ORGANOPHOSPHORUS COMPOUNDS; OXADIAZOLES;

EID: 48849112732     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol8004084     Document Type: Article

References (51)

1. (a) Borg, S.; Estenne-Bouhtou, G.; Luthman. K.; Csoeregh, I.; Hesselink, W.; Hacksell, U. J. Org. Chem. 1995, 60, 3112-3120.
2. (b) Poulain, R. R; Tartar, A. L.; Deprez. B. P. Tetrahedron Lett. 2001, 42, 1495-1498.
3. (c) Poindexter, G. S.; Bruce, M. A.; Breitenbucher, J. G.; Higgins, M. A.; Sit, S. Y.; Romine, J. L.; Martin, S. W.; Ward, S. A.; McGovem, R. T.; Clarke, W.; Russell. J.; Antal-Zimanyi, I. Bioorg. Med. Chem. 2004, 12, 507-521.
4. (d) Elzein, E.; Ibrahim, P.; Koltun, D. O.; Rehder, K.; Shenk, K. D.; Marquart, T. A.; Jiang, B.; Li, X.; Natero, R.; Li. Y.; Nguyen, M.; Kerwar, S.; Chu, N.; Soohoo, D.; Hao, J.; Maydanik, V. Y.; Lustig, D. A.; Zeng. D.; Leung, K.; Zablocki, J. A. Bioorg. Med. Chem. Lett. 2004, 14, 6017-6021.
5. (a) Biological activity of 1,3,4-oxadiazoles: Yale, H. L.: Losee, K. J. Med. Chem. 1966, 9, 478-483.
6. (b) Holla, B. S.; Gonsalves. R.; Shenoy, S. Eur. J. Med. Chem. 2000, 35, 267-271.
7. (c) Zou. X.-J.; Lai, L.-H.; Jin, G.-Y.; Zhang, Z.-X. J. Agric. Food Chem. 2002, 50, 3757-3760.
8. (d) Laddi, U. V.; Desai, S. R.; Bennur. R. S.; Bennur, S. C. Indian .1. Heterocycl. Chem. 2002, 11, 319-322.
9. (e) Palaska, E.; §ahin, G.; Kelicen. P.; Durlu, N. T.; Altinok, G. Farmaco 2002, 57, 101-107.
10. (f) Antimitotics : Ghiran, D.; Schwartz, I.; Simiti, I. Farmacia 1974, 22, 141-146.
11. (g) Rai, K. M. L.; Linganna, N. Farmaco 2000, 55, 389-392.
12. (h) Anti-inflammatories : Omar. F. A.; Mahfouz, N. M.; Rahman, M. A Eur. J. Med. Chem. 1996, 31, 819- 825.
13. (i) Antineoplastics : Rostom, S. A. F.; Shalaby. M. A.; El-Demellawy, M. A. Eur. J. Med. Chem. 2003, 38, 959-974.
14. (j) Anticonvulsants: Ergenc, N.: Capan, G. Farmaco 1994, 49, 449-451.
15. (a) Wilkie, G. D.; Elliott, G. I.; Blagg, B. S. J.; Wolkenberg, S. E.; Soenen, D. R.; Miller, M. M.; Pollack, S.; Boger, D. L. J. Am. Chem. Soc. 2002, 124, 11292-11294, and references therein
16. (b) Choi, Y.; Ishikawa, H.; Velcicky, J.; Elliott. G. I.; Miller, M. M.; Boger, D. L. Org. Lett. 2005, 7, 4539-4542.
17. (c) Ishikawa, H.; Elliott. G. I.; Velcicky, J.; Choi, Y.: Boger. D. L. J. Am. Chem. Soc. 2006, 128, 10596-10612.
18. Confalone, P. N.; Woodward, R. B. J. Am. Chem. Soc. 1983, 105. 902-906.
19. Brain, C. T.; Paul, J. M.; Loong. Y.: Oakley, P. J. Tetrahedron Lett. 1999, 40, 3275-3278.
20. (a) Appel, R. Angew. Chem., Int. Ed. Engl. 1975, 14, 801-811.
21. (b) Košmrlj, J.; Kočevar, M.; Polanc, S. Synlett 1996, 652-654.
22. (c) Mazurkiewicz, R.; Grymel, M. Pol. J. Chem. 1997, 71, 77-82.
23. (d) Dumčiutė, J.; Martynaitis, V.; Holzer, W.; Mangelinckx, S.; De Kirnpe, N.; Sackus, A. Tetrahedron 2006, 62, 3309-3319.
24. (a) AboulWafa, O. M.; Omar. A. M. M. E. Sulfur Lett. 1992, 14. 181-188.
25. (b) Coppo, F. T.; Evans, K. A.; Graybill, T. L.; Burton, G. Tetrahedron Lett. 2004, 45, 3257-3260.
26. (c) Baxendale, I. R.; Ley, S. V.; Martinelli, M. Tetrahedron 2005, 61, 5323-5349.
27. (d) Severinsen, R.; Kilburn, J. P.; Lau, J. F. Tetrahedron 2005, 61, 5565-5575.
28. Dolman, S. J.; Gosselin, F.; O'Shea, P. D.; Davies, I. W. J. Org. Chem. 2006. 71, 9548-9551.
29. Wang, X.; Li, Z.; Wei, B.; Yang, J. Synth. Commun. 2002, 32, 1097- 1103.
30. (a) Madhavan, R.; Srinivasan, V. R. Ind. J. Chem. 1969, 7, 760-765.
31. (b) Alternate route to 2-chloro-l,3,4-oxadiazoles: Deshukh, M. B.; Shelar, M. A.; Mulik, A. R. Ind. J. Heterocycl. Chem. 2000, 10, 13-16.
32. (a) Hoggarth, E. J. Chem. Soc. 1949, 1918-1923.
33. (b) Direct amination of oxadiazole-2-thiones has been reported : Laddi, U. V.; Desai, S. R.; Bennur, R. S.; Bennur, S. C. Ind. J. Heterocycl. Chem. 2002, 11, 319-322.
34. (c) Honnalli, S. S.; Ronad, P. M.; Vijaybhasker, K.; Jukkeri, V. I.; Kumar, R. Heterocycl. Commun. 2005, 11, 505-508.
35. (a) Wan, z-K.; Binnun, E.; Wilson, D. P.; Lee, J. Org. Lett. 2005, 7, 5877-5880.
36. (b) Wan, Z.-K.; Wacharasindhu, S.; Binnun, E.; Mansour, T. Org. Lett. 2006, 8, 2425-2428.
37. (c) Wan, Z.-K.; Wacharasindhu, S.; Levins, C. G.; Lin, M.: Tabei, K.; Mansour, T. S. i. Org. Chem. 2007, 72, 10194-10210.
38. -.
39. Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Tetrahedron Lett. 1975, 14, 1219-1222.
40. (a) Smith, A. E. W. Science 1954, 119. 514.
41. (b) Stempel, A.; Zelauskas, J.; Aeschlimann, J. A. J. Org. Chem. 1955. 20, 412-418.
42. (c) Rosen, G. M.; Popp, F. D.; Gemmill, F. Q., Jr. J. Heterocycl. Chem. 1971, 8, 659-662.
43. (d) Thompson, S. K.; Smith, W. W.; Zhao, B.; Halbert, S. M.; Tomaszek, T. A.; Tew, D. G.; Levy, M. A.; Janson, C. A.; D'Alessio, K. J.; McQueney, M. S.; Kurdyla, J.; Jones, C. S.; DesJarlais, R. L.: Abdel-Meguid, S. S.: Veber, D. F. J. Med. Chem. 1998, 41, 3923-3927.
44. Grzyb, J. A.; Dekeyser, M. A.; Batey, R. A. Synthesis 2005, 2384-2392.
45. 2O was used to calibrate LCMS analysis.
46. (a) Castro, B.; Dormoy, J. R. Tetrahedron Lett. 1973, 14, 3243-3246.
47. (b) Coste, J.; Le-Nguyen, D.; Castro, B. Tetrahedron Lett. 1990, 31, 205-208.
48. (c) Carpino, L. A.; El-Faham, A.; Albericio, F. Tetrahedron Lett. 1994, 35, 2279-2282.
49. 3 as base.
50. NMP was used to avoid problems with DMF decomposition.
51. We are currently extending this method to other biologically interesting scaffolds and also exploring the use of these reagents for heterocycle synthesis through intramolecular cyclizations.